[Application of anti-cD154, anti-CD25 and anti-CD152 antibodies--attempt to achieve immunological tolerance].
Sołdacki
Dariusz
D
Klinika Immunologii, Transplantologii i Chor6b Wewnetrznych Instytutu Transplantologii AM w Warszawie.
Foroncewicz
Bartosz
B
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000494:pharmacology; D015703:Antigens, CD / Q000276:immunology* / Q000627:therapeutic use; D000943:Antigens, Differentiation / Q000276:immunology* / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D023201:CD40 Ligand / Q000276:immunology* / Q000627:therapeutic use; D060908:CTLA-4 Antigen; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology*; D053645:Interleukin-2 Receptor alpha Subunit / Q000276:immunology* / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D053645:Interleukin-2 Receptor alpha Subunit; D023201:CD40 Ligand